









Markets
/
Stocks
/
nasdaq-indv
/

Indivior PLC

INDV

View Detailed Chart

21.050USD

+0.850+4.21%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

2.63BMarket Cap

LossP/E TTM



Indivior PLC

21.050

+0.850+4.21%

Overview Company Financials

Financials

Intraday

30m

Today

+4.21%

5 Days

+22.81%

1 Month

+36.60%

6 Months

+79.45%

Year to Date

+69.35%

1 Year

+55.12%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 5 analysts

BUY

Current Rating

25.400

Target Price

20.67%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Indivior PLC

INDV

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(0)

Buy(7)

Indicators

Sell(1)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.752

Buy

RSI(14)

87.717

Overbought

STOCH(KDJ)(9,3,3)

92.790

Overbought

ATR(14)

0.871

High Vlolatility

CCI(14)

224.084

Overbought

Williams %R

0.657

Overbought

TRIX(12,20)

0.996

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

18.604

Buy

MA10

17.570

Buy

MA20

16.559

Buy

MA50

14.689

Buy

MA100

12.450

Buy

MA200

11.514

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Indivior PLC is a pharmaceutical company. The Company is engaged in developing medicines to treat substance use disorders (SUD), serious mental illnesses, and opioid overdose. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder, and co-morbidities, including schizophrenia. Its core products include SUBLOCADE (buprenorphine extended release) monthly injection; SUBOXONE Film (buprenorphine and naloxone sublingual film); SUBOXONE Tablet (buprenorphine and naloxone sublingual tablets), and SUBUTEX Tablet (buprenorphine sublingual tablets). Its products for the treatment of opioid disorders (OUD) are OPVEE (nalmefene) nasal spray for opioid overdose reversal, and PERSERIS (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults in the United States. Its portfolio of products is available in 37 countries.

Ticker SymbolINDV

CompanyIndivior PLC

CEOMr. Joseph J. (Joe) Ciaffoni

Websitehttps://www.indivior.com/en